| Stage | MAR | % of rev | PK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.0B | 100.00% | $680M | 100.00% | MAR ×10.30 |
| Gross profit | $1.5B | 22.03% | $269M | 39.56% | PK +17.5pp |
| Operating income | $1.3B | 18.19% | $95M | 13.97% | MAR +4.2pp |
| Pre-tax income | $1.1B | 15.13% | $55M | 8.09% | MAR +7.0pp |
| Net income | $794M | 11.33% | $50M | 7.35% | MAR +4.0pp |
| Stage | MAR | PK | Gap · A − B |
|---|---|---|---|
| Revenue | $7.0B100.00% | $680M100.00% | MAR ×10.30 |
| Gross profit | 22.03%$1.5B | 39.56%$269M | PK +17.5pp |
| Operating income | 18.19%$1.3B | 13.97%$95M | MAR +4.2pp |
| Pre-tax income | 15.13%$1.1B | 8.09%$55M | MAR +7.0pp |
| Net income |
| 11.33%$794M |
| 7.35%$50M |
| MAR +4.0pp |
No shared counterparties.